AARTIDRUGS:NSE Aarti Drugs Limited

INR 530.50 0.00 0
Icon

Aarti Drugs Limited (AARTIDRUGS:NSE) Stock Analysis and Price Targets

COMMON STOCK | Drug Manufacturers - Specialty & Generic | NSE
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

INR 530.50

0.00 (0.00)%

INR 49.26B

0.09M

INR 610.00(+14.99%)

N/A

Icon

AARTIDRUGS:NSE

Aarti Drugs Limited (INR)
COMMON STOCK | NSE
INR 530.50
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

INR 49.26B

N/A

INR 530.50

Aarti Drugs Limited (AARTIDRUGS:NSE) Stock Forecast

INR 610.00
(+14.99%)

Based on the Aarti Drugs Limited stock forecast from 1 analysts, the average analyst target price for Aarti Drugs Limited is INR 610.00 over the next 12 months. Aarti Drugs Limited’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Aarti Drugs Limited is Bearish, which is based on 3 positive signals and 8 negative signals. At the last closing, Aarti Drugs Limited’s stock price was INR 530.50. Aarti Drugs Limited’s stock price has changed by +0.10% over the past week, -0.89% over the past month and +45.74% over the last year.

No recent analyst target price found for Aarti Drugs Limited
No recent average analyst rating found for Aarti Drugs Limited

Company Overview Aarti Drugs Limited

Aarti Drugs Limited, through its subsidiaries, engages in the manufacturing and marketing of active pharmaceutical ingredients (APIs), pharmaceutical intermediates, specialty chemicals, and formulations in India and internationally. The company provides APls in various therapeuti...Read More

Mahendra Industrial Estate, Mumbai, India, 400022

1,003

March

INR

India

Adjusted Closing Price for Aarti Drugs Limited (AARTIDRUGS:NSE)

Loading...

Unadjusted Closing Price for Aarti Drugs Limited (AARTIDRUGS:NSE)

Loading...

Share Trading Volume for Aarti Drugs Limited Shares

Loading...

Compare Performance of Aarti Drugs Limited Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for AARTIDRUGS:NSE

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Aarti Drugs Limited (Sector: Drug Manufacturers - Specialty & Generic )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
SUNPHARMA:NSE
Sun Pharmaceutical Industries .. 0.00 (0.00%) INR2,788.98B 32.61 30.46

ETFs Containing AARTIDRUGS

Symbol Name AARTIDRUGS's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Aarti Drugs Limited (AARTIDRUGS:NSE) Stock

Based on ratings from 1 analysts Aarti Drugs Limited's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 1 buy, sell and hold ratings.

AARTIDRUGS:NSE stock's dividend yield is 0.19%. Our analysis grades AARTIDRUGS:NSE stock's dividend yield at F. This means that AARTIDRUGS:NSE stock's dividend yield is above 6% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the NSE exchange. Based on this AARTIDRUGS:NSE may be a poor dividend stock for its sector.

Based on targets from 1 analysts, the average taret price for AARTIDRUGS:NSE is INR 610.00 over the next 12 months. The maximum analyst target price is INR 610 while the minimum anlayst target price is INR 610.

AARTIDRUGS:NSE stock's Price/Earning ratio is 27.09. Our analysis grades AARTIDRUGS:NSE stock's Price / Earning ratio at D-. This means that AARTIDRUGS:NSE stock's Price/Earning ratio is above 39% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the NSE exchange. Based on this AARTIDRUGS:NSE may be fairly valued for its sector

The last closing price of AARTIDRUGS:NSE's stock was INR 530.50.

The most recent market capitalization for AARTIDRUGS:NSE is INR 49.26B.

Based on targets from 1 analysts, the average taret price for AARTIDRUGS:NSE is projected at INR 610.00 over the next 12 months. This means that AARTIDRUGS:NSE's stock price may go up by +14.99% over the next 12 months.

We can't find any ETFs which contains Aarti Drugs Limited's stock.

As per our most recent records Aarti Drugs Limited has 1,003 Employees.

Aarti Drugs Limited's registered address is Mahendra Industrial Estate, Mumbai, India, 400022. You can get more information about it from Aarti Drugs Limited's website at https://www.aartidrugs.co.in.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...